Coordinatore | TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY
Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie. |
Nazionalità Coordinatore | Israel [IL] |
Totale costo | 1˙600˙000 € |
EC contributo | 1˙600˙000 € |
Programma | FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
Code Call | ERC-2007-StG |
Funding Scheme | ERC-SG |
Anno di inizio | 2008 |
Periodo (anno-mese-giorno) | 2008-08-01 - 2013-07-31 |
# | ||||
---|---|---|---|---|
1 |
TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY
Organization address
address: TECHNION CITY - SENATE BUILDING contact info |
IL (HAIFA) | hostInstitution | 0.00 |
2 |
TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY
Organization address
address: TECHNION CITY - SENATE BUILDING contact info |
IL (HAIFA) | hostInstitution | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Direct activation of retinal ganglion cells is a promising approach for treating blindness resulting from degenerative diseases of the outer retina. Current neuro-retinal stimulation interfaces being developed use electrical currents from micro-electrode arrays, but future systems could use light patterns to create spatio-temporally complex activity patterns. We will develop, optimize and test different concepts allowing patterned optical stimulation of large populations of retinal ganglion cells based on emerging methods for light-based neuro-stimulation, including glutamate uncaging and ectopic expression of the light-sensitive ion channel Channelrhodopsin II. A series of in vitro and in vivo experiments will examine basic questions regarding the efficacy and safety of this general approach. Our experiments will define the major engineering requirements and constraints towards the development of a light-based approach for restoring vision in individuals with outer-retinal degenerative diseases.'